Thyssenkrupp on Tuesday reported a 1-billion-euro ($1 billion) impairment on its struggling steel division.
Jefferies says buy this pharmaceutical play, sees more than 100% upside from here
This pharmaceutical company’s recent drug developments could spell more gains ahead, according to Jefferies.